Market Research Report
Advances in Monoclonal Antibody Therapeutics
|Published by||Frost & Sullivan||Product code||340911|
|Published||Content info||94 Pages
Delivery time: 1-2 business days
|Advances in Monoclonal Antibody Therapeutics|
|Published: September 29, 2015||Content info: 94 Pages||
Monoclonal antibody therapeutics are being used for treatment of a wide array of diseases, specially in therapeutic areas such as oncology, immunology (including autoimmune and inflammatory diseases, as well as, transplant rejection) and neuroscience. The development of these new molecular agents, successfully directed to specific cellular targets, is playing a crucial role in the pharmaceutical industry. This trend shows the strong focus of top biopharmaceutical companies in biologics, including monoclonal antibody therapeutics. This research service discusses the emerging trends in monoclonal antibody therapeutics on a global scale, through a detailed strategic assessment of the industry environment.